Zobrazeno 1 - 4
of 4
pro vyhledávání: '"pediatric malignant and nonmalignant diseases"'
Autor:
Irina Zaidman, Tamar Shaziri, Dina Averbuch, Ehud Even-Or, Yael Dinur-Schejter, Adeeb NaserEddin, Rebecca Brooks, Bella Shadur, Aharon Gefen, Polina Stepensky
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundAllogeneic hematopoietic stem cell transplantation (HSCT) is an efficient treatment for numerous malignant and nonmalignant conditions affecting children. This procedure can result in infectious and noninfectious neurological complications
Externí odkaz:
https://doaj.org/article/22b74a28384544a5aeb9e1ca75d0bbfd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zaidman I; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Mohamad H; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Shalom L; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Ben Arush M; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel., Even-Or E; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Averbuch D; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Zilkha A; Pediatric Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel., Braun J; Pediatric Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel., Mandel A; Pediatric Intensive Care Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Kleid D; Pediatric Intensive Care Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Attias O; Pediatric Intensive Care Unit, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel., Ben-Ari J; Pediatric Intensive Care Unit, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel., Brooks R; Pediatric Intensive Care Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Gefen A; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel., Stepensky P; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Mar; Vol. 69 (3), pp. e29549. Date of Electronic Publication: 2021 Dec 30.